AIG vs TERN · P/E 21, rev $7.18B vs $6.12B cap
American International Group Inc (AIG) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported AIG revenue for 2024-12-31 was $7.18B. Net income was $901.0M. Revenue was up 6.3% from 2024-09-30 to 2024-12-31. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. TERN currently screens at market cap $6.12B.
Not investment advice. Open the AIG and TERN stock pages for the full models.
Not investment advice.